Teferon 120 Injection

Опис товару

About Teferon 120 Injection

Teferon 120 Injection is a prescription medicine that contains the active ingredient Pegylated Interferon Alpha 2B. It is formulated as a sterile solution for intramuscular or subcutaneous injection. The product is intended for use under the supervision of a qualified healthcare professional. Teferon 120 Injection is supplied in pre‑filled syringes that contain a single dose of the medication. The formulation is designed to provide a controlled release of interferon, allowing for sustained therapeutic effects. The product is manufactured in accordance with Good Manufacturing Practice (GMP) standards and is subject to rigorous quality control testing. The packaging includes a safety cap and a clear dosage indicator to aid in accurate administration. Teferon 120 Injection is part of a class of antiviral and immunomodulatory agents used in the treatment of certain viral infections and autoimmune conditions. The product is available only with a prescription and should be stored in a cool, dry place away from direct sunlight.

Key Benefits & Uses

• Provides antiviral activity against hepatitis B and C viruses.
• Modulates the immune response in certain autoimmune disorders.
• Offers a convenient dosing schedule with extended half‑life.

Active Ingredient & Action

The active ingredient, Pegylated Interferon Alpha 2B, is a recombinant protein that mimics the natural interferon alpha. It binds to specific receptors on target cells, triggering a cascade of antiviral and immunomodulatory pathways. The pegylation process increases the molecule’s stability and prolongs its presence in the bloodstream, allowing for less frequent dosing while maintaining therapeutic levels. This mechanism helps inhibit viral replication and enhances the body’s immune surveillance against infected cells.

Important Notes

Teferon 120 Injection should be used only as directed by a healthcare professional. Patients should inform their clinician of any history of liver disease, autoimmune disorders, or other medications they are taking. The product is not intended for use in individuals with a known hypersensitivity to interferon or any of its components. Proper storage and handling procedures must be followed to preserve the integrity of the medication. Side effects may include flu‑like symptoms, injection site reactions, and changes in blood counts; any adverse reactions should be reported to a healthcare provider promptly. The medication is not suitable for use in pregnancy or breastfeeding without medical advice. The product is available only with a prescription and should be used in accordance with local regulatory guidelines.